# US 2022/0277807 A1 · Methods and systems for assessing genetic variants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0277807 A1
- Document ID: US20220277807A1
- Status: Published application
- Kind: A1
- Application number: 17/636,332
- Filed: 2020-08-21
- Published: 2022-09-01
- Earliest claimed: 2019-08-22
- Assignees: Inari Agriculture Technology, Inc.
- Applicants: Inari Agriculture Technology, Inc.
- Inventors: Karl Anton Grothe KREMLING; Stephen GOFF; Wenbin MEI; Ruijuan LI; Ross Everett ALTMAN; Zachary Hartford LEMMON
- Web page: https://patentgrep.com/patent/US20220277807A1

## CPC

- G16B 20/50: Mutagenesis
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Provided herein are methods for assessing genetic variants for use in genetically improving organisms and in human genetics and medicine. Also provided herein are systems for implementing such methods, as well as computer-readable storage media storing instructions for performing such methods.

## Claims

### Claim 1

A method for improving performance of an organism, comprising:
a) providing a plurality of genetic variants in the genome of the organism;
b) predicting the effects of the genetic variants on the performance of the organism using a statistical model;
c) altering one or more of the genetic variants in the genome of the organism;
d) identifying an impact of the alteration on an endophenotype, wherein the endophenotype is a quantifiable phenotype at the sub-organismal level that can be measured by a biochemical, gene expression, or protein level assay, or visually via microscopy;
e) updating the statistical model using the identified endophenotypic impact;
f) optionally repeating steps c) to e) for one or more times;
g) determining the genetic variants having a predicted negative effect on the performance of the organism using the updated statistical model; and
h) modifying in the genome one or more of the genetic variants having a predicted negative effect on the performance of the organism, thereby improving performance of an organism.

### Claim 2

A method for selecting an organism with improved performance in a population, comprising:
a) providing a population of organisms;
b) providing a plurality of genetic variants of the population;
c) predicting the effects of the genetic variants on the performance of the organisms using a statistical model;
d) altering one or more of the genetic variants in one or more of the organisms;
e) identifying an impact of the alteration on an endophenotype, wherein the endophenotype is a quantifiable phenotype at the sub-organismal level that can be measured by a biochemical, gene expression, or protein level assay, or visually via microscopy;
f) updating the statistical model using the identified endophenotypic impact;
g) optionally repeating steps d) to f) for one or more times;
h) determining the genetic variants having predicted positive effects on the performance of the organisms using the updated statistical model; and
i) selecting in the population an organism comprising one or more of the genetic variants having predicted positive effects on the performance of the organisms, selecting an organism with improved performance in a population.

### Claim 3

A method for removing an underperforming organism from a population, comprising:
a) providing a population of organisms;
b) providing a plurality of genetic variants of the population;
c) predicting the effects of the genetic variants on the performance of the organisms using a statistical model;
d) altering one or more of the genetic variants in one or more of the organisms;
e) identifying an impact of the alteration on an endophenotype, wherein the endophenotype is a quantifiable phenotype at the sub-organismal level that can be measured by a biochemical, gene expression, or protein level assay, or visually via microscopy;
f) updating the statistical model using the identified endophenotypic impact;
g) optionally repeating steps d) to f) for one or more times;
h) determining the genetic variants having predicted negative effects using the updated statistical model; and
i) removing from the population an organism comprising one or more of the genetic variants having predicted negative effects on the performance of the organisms, thereby removing an underperforming organism from a population.

### Claim 4

A method for prioritizing genetic variants based on predicted effects on performance of an organism, comprising:
a) providing a plurality of genetic variants in the genome of the organism;
b) predicting the effects of the genetic variants on the performance of the organism using a statistical model;
c) altering one or more of the genetic variants in the genome of the organism;
d) identifying an impact of the alteration on an endophenotype, wherein the endophenotype is a quantifiable phenotype at the sub-organismal level that can be measured by a biochemical, gene expression, or protein level assay, or visually via microscopy;
e) updating the statistical model using the identified endophenotypic impact;
f) optionally repeating steps c) to e) for one or more times; and
g) prioritizing the genetic variants based on the magnitudes of the predicted effects on the performance of organism using the updated statistical model.

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the organism is maize, wheat, barley, oat, rice, soybean, oil palm, safflower, sesame, tobacco, flax, cotton, sunflower, pearl millet, foxtail millet, sorghum, canola, cannabis, a vegetable crop, a forage crop, an industrial crop, a woody crop, or a biomass crop.

### Claim 6 (depends on 5)

The method of claim 5, wherein the performance of the organism is yield, overall fitness, biomass, photosynthetic efficiency, nutrient use efficiency, heat tolerance, drought tolerance, herbicide tolerance, or disease resistance.

### Claim 7 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the organism is cattle, sheep, goat, horse, pig, chicken, duck, goose, rabbit, or fish.

### Claim 8 (depends on 7)

The method of claim 7, wherein the performance of the organism is growth rate, feed use efficiency, meat yield, meat quality, milk yield, milk quality, egg yield, egg quality, wool yield, or wool quality.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of any one of claims 1-8, wherein the performance is a quantitative trait.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1-9, wherein the genetic variants are identified by a linkage study.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1-9, wherein the genetic variants are identified by an association study.

### Claim 12 (depends on 11)

The method of claim 11, wherein the association study is a genome-wide association study (GWAS) or a transcriptome-wide association study (TWAS).

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein the statistical model is a linear regression model, a logistic regression model, a ridge regression model, a lasso regression model, an elastic net regression model, a decision tree model, a gradient boosted tree model, a neural network model, or a support vector machine (SVM) model.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein the statistical model comprises a feature based on evolutionary conservation of the genetic variants.

### Claim 15 (depends on 14)

The method of claim 14, wherein the evolutionary conservation is determined by sequence alignment in a genic or an intergenic region.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein the statistical model comprises a feature based on functional impact of amino acid change of the genetic variants.

### Claim 17 (depends on 16)

The method of claim 16, wherein the functional impact of amino acid change is weighted according to the blocks substitution matrix (BLOSUM).

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein the statistical model comprises a feature based on functional impact of protein conformation and/or stability of the genetic variants.

### Claim 19 (depends on 18)

The method of claim 18, wherein the functional impact of protein conformation and/or stability is determined by a Monte Carlo search for minimal free energy.

### Claim 20 (depends on 18)

The method of claim 18, wherein the functional impact of protein conformation and/or stability is predicted by learning a representation of amino acid order from existing proteins in higher dimensional space.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein the statistical model comprises a feature based on adjacency to a selective sweep region of the genetic variants.

### Claim 22 (depends on 21)

The method of claim 21, wherein the selective sweep region is determined by a decrease of pairwise nucleotide diversity it or linkage disequilibrium relative to the rest of the genome.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein the statistical model comprises a feature based on outlier status of an endophenotype associated with a genetic variant that is physically proximal or proximal within a gene network.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The method of any one of claims 1-23, wherein the alteration is achieved by genome editing.

### Claim 25 (depends on 24)

The method of claim 24, wherein the genome editing is achieved by a clustered regularly interspersed short palindromic repeats (CRISPR) system, a transcription activator-like effector nuclease (TALEN) system, or a zinc finger nuclease (ZFN) system.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The method of any one of claims 1-23, wherein the alteration is achieved by creation of novel haplotype combinations from genetic recombination during meiosis.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is messenger RNA (mRNA) abundance.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is gene transcript splicing ratio.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is protein abundance.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is micro RNA (miRNA) or small RNA (siRNA) abundance.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is translational efficiency.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is ribosome occupancy.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is protein modification.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is metabolite abundance.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1-26, wherein the endophenotype is allele specific expression (ASE).

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

An organism with improved performance produced or selected by the method of any one of claims 1-35.

### Claim 37

A computer-implemented method for assessing genetic variants for use in genetic improvement of an organism, comprising:
a) receiving a dataset comprising a plurality of genetic variants of the organism; and
b) performing a prediction of the effects of the genetic variants using a statistical model comprising one or more initial rules that associate the genetic variants with performance of the organism.

### Claim 38 (depends on 37)

The method of claim 37, further comprising updating the statistical model with one or more new rules, wherein the one or more new rules are based on data generated from an endophenotype, wherein the endophenotype is a quantifiable phenotype at the sub-organismal level that can be measured by a biochemical, gene expression, or protein level assay, or visually via microscopy.

### Claim 39 (depends on 37, 38)

The method of any one of claims 37-38, wherein the statistical model is a linear regression model, a logistic regression model, a ridge regression model, a lasso regression model, an elastic net regression model, a decision tree model, a gradient boosted tree model, a neural network model, or a support vector machine (SVM) model.

### Claim 40 (depends on 37, 38, 39)

The method of any one of claims 37-39, wherein the one or more initial rules or the one or more new rules comprise evolutionary conservation, functional impact of amino acid change, functional impact of protein conformation and/or stability, adjacency to selective sweep regions, outlier status of an endophenotype associated with a genetic variant that is physically proximal or proximal within a gene network, or a combination thereof.

### Claim 41 (depends on 38, 39, 40)

The method of any one of claims 38-40, wherein the endophenotype is messenger RNA (mRNA) abundance, gene transcript splicing ratio, protein abundance, micro RNA (miRNA) or small RNA (siRNA) abundance, translational efficiency, ribosome occupancy, protein modification, metabolite abundance, allele specific expression (ASE), or a combination thereof.

### Claim 42

A computer-readable storage medium storing computer-executable instructions, comprising:
a) instructions for applying a statistical model to a dataset,
wherein the dataset comprises a plurality of genetic variants of an organism, and
wherein the statistical model comprises one or more initial rules that associate the genetic variants with performance of the organism; and
b) instructions for calculating an effect value related to the performance of the organism for each of the genetic variants.

### Claim 43 (depends on 42)

The computer-readable storage medium of claim 42, further comprising instructions for updating the statistical model with at least one new rule, wherein at least one new rule is based on data generated from an endophenotype, wherein the endophenotype is a quantifiable phenotype at the sub-organismal level that can be measured by a biochemical, gene expression, or protein level assay, or visually via microscopy.

### Claim 44 (depends on 42, 43)

The computer-readable storage medium of any one of claims 42-43, wherein the statistical model is a linear regression model, a logistic regression model, a ridge regression model, a lasso regression model, an elastic net regression model, a decision tree model, a gradient boosted tree model, a neural network model, or a support vector machine (SVM) model.

### Claim 45 (depends on 42, 43, 44)

The computer-readable storage medium of any one of claims 42-44, wherein the one or more initial rules or the one or more new rules comprise evolutionary conservation, functional impact of amino acid change, functional impact of protein conformation and/or stability, adjacency to selective sweep regions, outlier status of an endophenotype associated with a genetic variant that is physically proximal or proximal within a gene network, or a combination thereof.

### Claim 46 (depends on 43, 44, 45)

The computer-readable storage medium of any one of claims 43-45, wherein the endophenotype is messenger RNA (mRNA) abundance, gene transcript splicing ratio, protein abundance, micro RNA (miRNA) or small RNA (siRNA) abundance, translational efficiency, ribosome occupancy, protein modification, metabolite abundance, allele specific expression (ASE), or a combination thereof.

### Claim 47

A system for assessing genetic variants for use in genetic improvement of an organism, comprising:
a) a computer-readable storage medium storing a database comprising a plurality of genetic variants of the organism;
b) a computer-readable storage medium storing computer-executable instructions, comprising:
i) instructions for applying a statistical model to the dataset,
wherein the statistical model comprises one or more initial rules that associate the genetic variants with performance of the organism; and
ii) instructions for calculating an effect value related to the performance of the organism for each of the genetic variants; and
c) a processor configured to execute the computer-executable instructions stored in the computer-readable storage medium.

### Claim 48 (depends on 47)

The system of claim 47, wherein the computer-readable storage medium further comprises instructions for updating the statistical model with one or more new rules, wherein the one or more new rules are based on data generated from an endophenotype, wherein the endophenotype is a quantifiable phenotype at the sub-organismal level that can be measured by a biochemical, gene expression, or protein level assay, or visually via microscopy.

### Claim 49 (depends on 47, 48)

The system of any one of claims 47-48, wherein the statistical model is a linear regression model, a logistic regression model, a ridge regression model, a lasso regression model, an elastic net regression model, a decision tree model, a gradient boosted tree model, a neural network model, or a support vector machine (SVM) model.

### Claim 50 (depends on 47, 48, 49)

The system of any one of claims 47-49, wherein the one or more initial rules or the one or more new rules comprise evolutionary conservation, functional impact of amino acid change, functional impact of protein conformation and/or stability, adjacency to selective sweep regions, outlier status of an endophenotype associated with a genetic variant that is physically proximal or proximal within a gene network, or a combination thereof.

### Claim 51 (depends on 48, 49, 50)

The system of any one of claims 48-50, wherein the endophenotype is messenger RNA (mRNA) abundance, gene transcript splicing ratio, protein abundance, micro RNA (miRNA) or small RNA (siRNA) abundance, translational efficiency, ribosome occupancy, protein modification, metabolite abundance, allele specific expression (ASE), or a combination thereof.

### Claim 52

A method for prioritizing genetic variants, comprising:
a) providing a plurality of genetic variants in the genome of an organism;
b) predicting the effects of the genetic variants on the performance of the organism using an endophenotype; and
c) prioritizing the genetic variants based on the magnitudes of the predicted effects on the performance of the organism.

### Claim 53 (depends on 52)

The method of claim 52, further comprising altering one or more of the prioritized genetic variants in the organism.

### Claim 54 (depends on 52)

The method of claim 52, further comprising selecting one or more of the prioritized genetic variants from a population of the organisms.

### Claim 55 (depends on 52, 53, 54)

The method of any one of claims 52-54, wherein the endophenotype is allele specific expression (ASE).

### Claim 56 (depends on 52, 53, 54, 55)

The method of any one of claims 52-55, wherein the statistical model comprises calculating the effect of a genetic variant on the biological function of a protein.

### Claim 57 (depends on 56)

The method of claim 56, wherein the calculated effect of a genetic variant is a likelihood ratio test P-value, a Protein Variation Effect Analyzer (PROVEAN) score, or a Sorting Intolerant from Tolerant (SIFT) score.

### Claim 58 (depends on 52, 53, 54, 55, 56, 57)

The method of any one of claims 52-57, wherein the organism is maize, wheat, barley, oat, rice, soybean, oil palm, safflower, sesame, tobacco, flax, cotton, sunflower, pearl millet, foxtail millet, sorghum, canola, cannabis, a vegetable crop, a forage crop, an industrial crop, a woody crop, or a biomass crop.

### Claim 59 (depends on 52, 53, 54, 55, 56, 57, 58)

The method of claim 52-58, wherein the organism is hybrid maize.

### Claim 60 (depends on 52, 53, 54, 55, 56, 57, 58, 59)

The method of any one of claims 52-59, wherein the performance of the organism is yield, overall fitness, biomass, photosynthetic efficiency, nutrient use efficiency, heat tolerance, drought tolerance, herbicide tolerance, or disease resistance.

### Claim 61 (depends on 52, 53, 54, 55, 56, 57, 58, 59, 60)

The method of any one of claims 52-60, wherein the genetic variants comprise a deleterious allele that confers or correlates with a negative effect to the performance of the organism.

### Claim 62 (depends on 61)

The method of claim 61, wherein the deleterious allele is overexpressed or underexpressed in the organism in comparison to a control organism.

### Claim 63 (depends on 62)

The method of claim 62, wherein the control organism is an inbred line.

### Claim 64 (depends on 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)

The method of any one of claims 52-63, wherein the genetic variants are homozygous or heterozygous in the organism.

### Claim 65 (depends on 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The method of any one of claims 52-64, wherein the genetic variants comprise a deleterious allele that is homozygous in the organism.

### Claim 66 (depends on 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The method of any one of claims 52-65, wherein the prioritized genetic variants comprise a target for gene editing.

### Claim 67 (depends on 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The method of any one of claims 52-66, wherein the prioritized genetic variants comprise a deleterious allele homozygous in the organism that is used as a target for gene editing.

### Claim 68 (depends on 66, 67)

The method of any one of claims 66-67, wherein the gene editing is achieved by a zinc finger nuclease (ZFN) system, a transcription activator-like effector nuclease (TALEN) system, or a clustered regularly interspersed short palindromic repeats (CRISPR) system.
